Meet the InPen™ smart insulin pen
InPen empowers you with actionable data you haven't had from your patients on multiple daily injections (MDI), until now.
InPen helps solve common challenges with MDI
A system that makes life easier for your patients
InPen helps people on MDI take the right amount of insulin at the right time, thanks to real-time tracking and decision support.
✓ Tracks active insulin
✓ Reminds user to dose
✓ Calculates personalized doses
✓ Automatically logs doses
✓ Syncs with CGMs and glucose meters
Intuitive and affordable decision support
InPen helps reduce the mental burden associated with diabetes management by providing personalized dosing amounts, keeping track of injections, and offering reminders for missed doses.
The InPen smart
insulin pen
The InPen app
Visibility of patient data
Advanced tracking and algorithms, along with intuitive reports, tell you and your patients more about their MDI therapy than ever before. Patients can share their InPen™ data with you at any time. See when and how much your patients are dosing, and get full visibility into their blood glucose and carb intake. At their next appointment, you can collaborate and identify new ways to help achieve their goals.
Example Patient Profile
Learn about InPen, a smarter diabetes management tool
Complete the form below and a sales representative will follow up with additional information.
How can we help you? Check all that apply. I would like:
Prescription information
How to prescribe InPen?
Option 1: Prescribe through EMR
Option 2: Complete the form above or fill out the form and email it to rx@companionmedical.com or fax to 877-44-2373.
How to dispense InPen?
InPen is currently available to order via Cardinal, McKesson and AmerisourceBergen. InPen comes in three colors and two different models.
Frequently asked questions
References
1. Randlov, J., Poulsen, J.U. J Diabetes Sci Technol. 2008 Mar; 2(2): 229-235. Published online 2008 Mar. doi: [10.1177/1932296 80800200209]
2. Garg SK, Bookout TR, McFann KK, et al. Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software. Diabetes Technology and Therapeutics. 2008; 10(5):369-375.
3. Zaugg, Stephanie D., et al. “Diabetes numeracy and blood glucose control: association with type of diabetes and source of care.” Clinical diabetes: a publication of the American Diabetes Association 32.4 (2014): 152-157.
4. Cavanaugh, Kerri, et al. “Association of numeracy and diabetes control.” Annals of Internal Medicine 148.10 (2008): 737-746.
5. Ziegler R, Cavan DA, Cranston I, et al. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. Diabetes Care. 2013; 36(11):3613-3619.
6. Kaufman FR, Halvorson M, Carpenter S. Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting in subjects with type 1 diabetes. Diabetes Care. 1999; 22(8):1252-1257.
7. Anderson DG. Multiple daily injections in young patients using the ezy-BICC bolus insulin calculation card, compared to mixed insulin and CSII. Pediatric Diabetes. 2009; 10(5):304-309.
* Humalog® is a registered trademark of Eli Lilly and Company. Fiasp® and Novolog® are registered trademarks of Novo Nordisk A/S.
† The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.
Important Safety Information: InPen™
The InPen™ is a home- use reusable pen injector for single- patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self- injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient- specific criteria and targets. The InPen™ requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenRisks.com.
Rx only. Under age 7 requires supervision of an adult caregiver. User interaction, compatible device, proper pairing and settings required. See http://bit.ly/InPenSafety
US-DBA-2100353